Lung Cancer News From Medical News Today
Complex Lung Cancer Treatments Delivered Successfully At Leading Varian-Equipped Proton Therapy Center
10:00:00 CEST +0200 September 9th, 2010
Clinicians at the Rinecker Proton Therapy Center (RPTC) in Munich are reporting using advanced proton therapy systems supplied by Varian Medical Systems (NYSE: VAR) for difficult lung cancer treatments. A 75-year-old patient with a large tumor in the right upper lung received 18 proton therapy treatments over three months...
Gene Set Identified That Shows Which Patients Benefit From Chemo After Surgery
09:00:00 CEST +0200 September 9th, 2010
Lung cancer researchers have identified a genetic signature that can help doctors determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease recurrence and therefore may benefit from chemotherapy after surgery ("adjuvant chemotherapy")...
New Model May Simplify High-Dose Radiosurgery Planning
09:00:00 CEST +0200 September 6th, 2010
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G...
Value Of Oxygen Therapy In End-Of-Life Care Challenged By Study
09:00:00 CEST +0200 September 4th, 2010
Millions of patients with advanced disease in palliative care settings receive oxygen therapy to help them breathe more easily. But a new study from Duke University Medical Center says roughly half of them don't benefit from the intervention, and among those who do benefit, it doesn't make a bit of difference whether they get pure oxygen or just plain old room air - both offer equal benefit...
In Lung Cancer, Tumor Budding Identified As Predictor For Unfavorable Outcome
09:00:00 CEST +0200 September 3rd, 2010
Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years...
Use Of In Vitro Drug Response Assay Shows Promise In Lung Cancer Treatment
09:00:00 CEST +0200 September 3rd, 2010
Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all...
Diabetes 2 Drug Metformin May Protect Against Lung Cancer In Smokers
15:00:00 CEST +0200 September 2nd, 2010
Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs...
American Lung Association Supports Individuals Dealing With Lung Disease Through Online Caregiving Coordination Service
14:00:00 CEST +0200 September 2nd, 2010
The American Lung Association is offering a free-of-charge, online caregiving coordination service called "My Fighting for Air Community" to support individuals affected by acute and chronic lung diseases...
Metformin May Protect Against Lung Cancer
12:00:00 CEST +0200 September 2nd, 2010
Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI). Results of this study will be published in the September issue of Cancer Prevention Research, a journal of the American Association for Cancer Research. Scott Lippman, M.D...
Plentiful And Varied Vegetable Consumption Lowers Lung Cancer Risk Considerably
15:00:00 CEST +0200 September 1st, 2010
People who consume a variety of vegetables tend to have a lower risk of developing lung cancer compared to those who don't, according to a study published in the medical journal Cancer Epidemiology, Biomarkers & Prevention, a publication of the American Association for Cancer Research...
Decreasing Lung Cancer Risk By Eating A Diverse Diet Of Vegetables
12:00:00 CEST +0200 September 1st, 2010
Adding a variety of vegetables to one's diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers. Study results are published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research...
Plant Agents Show Promise In Preventing Skin Cancer
09:00:00 CEST +0200 August 31st, 2010
Maybe you worshipped the sun in your youth or weren't as meticulous as you should have been with sunscreen. If so, take heart: Scientists at The University of Texas Health Science Center San Antonio are finding that certain plant substances, when given in combinations, may suppress damage that can cause skin cancer...
American Lung Association Joins Lung Cancer Clinical Trial Call To Action Campaign
14:00:00 CEST +0200 August 27th, 2010
The American Lung Association is encouraging patients with lung cancer to take charge of their diagnosis and learn about clinical trials through the Lung Cancer Clinical Trial Call to Action campaign. This service provides personalized education to quickly identify trial options that match each patient's specific diagnosis, stage, and treatment history...
Second-Hand Smoke May Provoke Inflammatory Response In Lungs
11:00:00 CEST +0200 August 27th, 2010
Second-hand smoke is associated with a number of diseases and conditions, including cancer, heart disease, and emphysema. It is an irritant to lung tissue and blood vessels, but the processes through which the body reacts to second-hand smoke comprise a mystery scientists are only beginning to unravel...
Stutent Did Not Improve Overall Survival In Patients With Previously Treated Advanced Non-small Cell Lung Cancer
00:00:00 CEST +0200 August 25th, 2010
The SUN 1087 trial of Stutent (sunitinib malate) combined with erlotinib versus just elrotinib did not improve overall survival in patients with previously treated NSCLC (non-small cell lung cancer), Pfizer Inc. informs. However, the combination therapy did demonstrate a significant improvement in progression free survival....
Topline Results From Phase 3 Trial Of Sunitinib With Erlotinib In Advanced Non-Small Cell Lung Cancer (NSCLC)
10:00:00 CEST +0200 August 24th, 2010
Pfizer Inc. (NYSE :PFE) announced that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival in patients with previously treated advanced non-small cell lung cancer (NSCLC)...
Arqule And Daiichi Sankyo Move Forward With Phase 3 Clinical Trial Plan For Arq 197 In Non-Small Cell Lung Cancer
11:00:00 CEST +0200 August 21st, 2010
ArQule, Inc. (Nasdaq: ARQL) and Daiichi Sankyo Co., Ltd. (TSE 4568) announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S...
ImmunoGen, Inc. Announces Orphan Drug Designation Granted To Lorvotuzumab Mertansine For Treatment Of Small-Cell Lung Cancer
10:00:00 CEST +0200 August 20th, 2010
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC)...
Palliative Care Improves Lung Cancer Patients' Quality Of Life And Helps Them Live Longer
10:00:00 CEST +0200 August 19th, 2010
Patients with advanced lung cancer who received integrated palliative care early on during treatment had a better quality of life and survived for two months longer compared to patients receiving standard care only, according to a study published in the August 19th issue of NEJM (New England Journal of Medicine)...
Lung Stem Cells Vital To Lung Repair Associated With Poor Cancer Prognosis When Found In Tumor
09:00:00 CEST +0200 August 19th, 2010
Adult stem cells that are vital for airway repair in the lung but that persist in areas where pre-cancerous lesions are found are associated with a poor prognosis in patients who develop cancer, even those with early stage disease, researchers at UCLA's Jonsson Comprehensive Cancer Center have found...
Discovery Of New Mechanisms Of Tumor Resistance To Targeted Therapy In Lung Cancer
09:00:00 CEST +0200 August 19th, 2010
One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time. A team led by Raffaella Sordella, Ph.D...
Project May Lead To New Approaches Against Lung Cancer
14:00:00 CEST +0200 August 18th, 2010
A Michigan State University researcher is analyzing the immune system's own ability to protect the body against lung cancer. The results of the work by Alison Bauer, an assistant professor of pathobiology and diagnostic investigation in the College of Veterinary Medicine, are expected to provide new approaches to prevent, identify and treat lung cancer...
Varian Medical Systems To Showcase Advanced Motion Management Technology For The Treatment Of Lung Cancer At CHINA-HOSPEQ 2010
11:00:00 CEST +0200 August 18th, 2010
Varian Medical Systems, Inc. (NYSE: VAR) will showcase the company's new Gated RapidArc technology on its Trilogy® machine with advanced motion management capabilities at the 2010 CHINA-HOSPEQ exhibition being held in Beijing August 19-21 by China's Ministry of Health...
Adult Lung Stem Cells Vital For Repair Associated With Poor Prognosis When Found In Excised Lung Cancer Tumors
11:00:00 CEST +0200 August 17th, 2010
Adult stem cells that are vital for airway repair in the lung but that persist in areas where pre-cancerous lesions are found are associated with a poor prognosis in patients who develop cancer, even those with early stage disease, researchers at UCLA's Jonsson Comprehensive Cancer Center have found...
No Association Between Estrogen, Lung Cancer Incidence And Mortality Among Postmenopausal Women
10:00:00 CEST +0200 August 16th, 2010
Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online in The Journal of the National Cancer Institute...
